Screenshot_4-removebg-preview.png
 

COVIAGE™ is a protective barrier enclosure that operates under negative pressure and uses HEPA filters to contain airborne particles such as virus droplets.

The device is intended to be used by healthcare providers on patients to provide an extra layer of barrier protection when caring for, transporting, or performing procedures on a patient who is known or suspected to have COVID-19.

The current device has received Emergency Use Authorization by the Food and Drug Administration (FDA). Additionally a utility patent has been filed.

What are the current challenges of providing patient care during the COVID-19 pandemic?

Limited supplies of personal protective equipment  (masks, gowns, face shields, etc.)

Limited supplies of personal protective equipment  (masks, gowns, face shields, etc.)

Unable to perform non-invasive ventilation procedures due to high aerosol production and hence danger to healthcare providers

Unable to perform non-invasive ventilation procedures due to high aerosol production and hence danger to healthcare providers

High exposure of healthcare providers to aerosolized virus particles

High exposure of healthcare providers to aerosolized virus particles

How does COVIAGE™ help?

Screenshot_1.jpg
Screenshot_2.jpg
Screenshot_3.jpg
IMG_6199.jpg

Features of COVIAGE™

  • Protects healthcare providers from COVID-19 exposure

  • Allows healthcare providers to perform >90% of patient care during use

  • Filters >99.997% of virus particulates

  • Easily removed in emergency situations

  • Disposable

  • Adaptable to different hospital beds / stretchers

Value of COVIAGE™

Screen Shot 2020-11-19 at 9.42.53 PM.png
Screen Shot 2020-11-19 at 9.45.33 PM.png
Screen Shot 2020-11-19 at 9.43.47 PM.png